Filing Flows › Atrium Therapeutics (RNA) › How it makes money
How Atrium Therapeutics (RNA) makes money
Atrium Therapeutics (RNA) made $3.0M of revenue in the second quarter 2026 (Q2 2026), -22% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $3.0M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $3.0M | -22% |
| Q1 2026 | $19.6M | 12× |
From Atrium Therapeutics' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Atrium Therapeutics make money?
Atrium Therapeutics (RNA) made $3.0M of revenue in the second quarter 2026 (Q2 2026), -22% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.